Try our mobile app

Switch to company model in "Rising Stars" logic    *

General information

Country: UNITED STATES

Sector: Medical Instruments and Supplies

Teleflex Incorporated is a global provider of medical technology products. The Company primarily develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications.
Website: teleflex.com


  • Good financial results growth rate 85.8% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (-6.5%)
  • Dividend yield for the last twelve months 0.8%
  • Free cash flow yield -10.5% (LTM)
  • Share price is 36.2% higher than minimum and 46.6% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (500.0x vs 26.0x)

Key Financials (Download financials)

Ticker: TFX
Share price, USD:  (+3.3%)136.71
year average price 118.14  


year start price 115.89 2025-08-02

min close price 100.34 2026-01-20

max close price 136.40 2026-07-13

current price 136.71 2026-08-01
Common stocks: 44 238 000

Dividend Yield:  0.8%
EV / Sales: 2.8x
Margin (EBITDA LTM / Revenue): -1.4%

Target EV / EBITDA (hist percentile): 26.0x
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 5 853
Net Debt ($m): 2 352
EV (Enterprise Value): 8 205
EBITDA LTM (млн $): -42
Price to Book: 1.6x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / EBITDA

Potential dynamics

News


2026-02-03globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX

2026-01-27globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Teleflex Incorporated - TFX

2026-01-13globenewswire.com

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teleflex Incorporated - TFX

2025-12-10seekingalpha.com

Teleflex: Selling, But How Much?

2025-11-14seekingalpha.com

Teleflex Incorporated (TFX) Discusses Strategic Rationale and Portfolio Overview of Acquired Vascular Intervention Business Transcript

2025-11-14globenewswire.com

Teleflex to Present at the Jefferies Global Healthcare Conference in London

2025-11-06seekingalpha.com

Teleflex Incorporated (TFX) Q3 2025 Earnings Call Transcript

2025-11-06globenewswire.com

Teleflex Announces Quarterly Dividend

2025-10-16globenewswire.com

Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details

2025-09-24zacks.com

TFX vs. PEN: Which Stock Should Value Investors Buy Now?
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-28 2025-06-29 2024-12-31 2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2022-12-31 2022-09-25 2021-12-31 2020-12-31
symbol TFX TFX TFX TFX TFX TFX TFX TFX TFX TFX TFX TFX TFX TFX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943
fillingDate 2025-11-06 2025-07-31 2024-10-31 2024-08-02 2024-05-03 2023-11-03 2023-08-03 2023-05-04 2022-10-27
acceptedDate 2025-11-06 10:01:33 2025-07-31 11:05:11 2025-02-28 08:46:38 2024-10-31 11:38:17 2024-08-02 09:08:26 2024-05-03 12:41:46 2024-02-23 12:23:11 2023-11-03 08:09:18 2023-08-03 12:02:11 2023-05-04 12:32:42 2023-02-23 13:28:21 2022-10-27 12:16:31 2022-03-01 10:58:40 2021-02-25 12:34:16
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 913M 781M 3 047M 764M 750M 738M 2 974M 746M 743M 711M 2 791M 687M 2 810M 2 537M
costOfRevenue 461M 350M 1 345M 334M 332M 322M 1 328M 330M 335M 320M 1 260M 313M 1 260M 1 212M
grossProfit 452M 431M 1 703M 430M 418M 416M 1 647M 416M 408M 391M 1 531M 374M 1 550M 1 325M
grossProfitRatio 0.495 0.552 0.563 0.557 0.564 0.558 0.549 0.551 0.544
researchAndDevelopmentExpenses 57M 39M 162M 39M 41M 37M 154M 38M 39M 41M 154M 38M 131M 120M
generalAndAdministrativeExpenses 0 0 0 0 0 381M 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 -138M 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 282M 215M 995M 247M 251M 243M 930M 213M 223M 233M 864M 210M 860M 744M
otherExpenses 142M 22M 395M 0 0 0 56M 0 0 0 14M 0 -69M 38M
operatingExpenses 481M 276M 1 552M 286M 292M 280M 1 141M 251M 263M 274M 1 031M 247M 922M 902M
costAndExpenses 943M 626M 2 896M 620M 624M 602M 2 468M 581M 598M 594M 2 291M 560M 2 181M 2 114M
interestIncome 2M 2M 8M 2M 2M 2M 13M 7M 1M 843 000 912 000 126 000 1M 1M
interestExpense 38M 22M 84M 21M 21M 23M 85M 23M 18M 18M 54M 13M 57M 66M
depreciationAndAmortization 78M 66M 275M 69M 68M 66M 242M 58M 60M 63M 231M 51M 237M 227M
ebitda -323M 223M 434M 225M 191M 202M 761M 231M 207M 178M 731M 183M 854M 651M
ebitdaratio -0.354 0.285 0.294 0.259 0.274 0.309 0.278 0.25 0.267
operatingIncome -30M 155M 151M 149M 126M 136M 506M 138M 144M 115M 500M 132M 628M 423M
operatingIncomeRatio -0.033 0.199 0.195 0.168 0.184 0.184 0.193 0.162 0.193
totalOtherIncomeExpensesNet -409M -20M -76M -19M -29M -162M -72M -231 000 -2M -17M -54M -13M -69M -65M
incomeBeforeTax -439M 135M 75M 131M 97M -26M 434M 150M 127M 97M 446M 119M 559M 358M
incomeBeforeTaxRatio -0.48 0.173 0.171 0.13 -0.035 0.2 0.171 0.137 0.174
incomeTaxExpense -30M 13M 5M 20M 17M -42M 76M 12M 16M 20M 83M 17M 74M 22M
netIncome -409M 123M 70M 111M 80M 15M 356M 137M 111M 77M 363M 102M 485M 335M
netIncomeRatio -0.448 0.157 0.145 0.107 0.021 0.184 0.15 0.108 0.148
eps -9.24 2.77 1.49 2.38 1.7 0.32 7.58 2.92 2.37 1.63 7.74 2.17 10.38 7.21
epsdiluted -9.24 2.77 2.36 1.69 0.32 2.9 2.35 1.62 2.16
weightedAverageShsOut 44M 46M 47M 47M 47M 47M 47M 47M 47M 47M 47M 47M 47M 46M
weightedAverageShsOutDil 44M 46M 47M 47M 47M 47M 47M 47M 47M 47M 47M 47M 47M 47M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-28 2024-02-23 2023-02-23 2022-03-01 2021-02-25
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -76M -72M -53M -56M -65M
ebit 159M 519M 500M 616M 424M
nonOperatingIncomeExcludingInterest -8M -13M -458 000 12M -1M
netIncomeFromContinuingOperations 70M 358M 363M 485M 336M
netIncomeFromDiscontinuedOperations -487 000 -1M 223 000 255 000 -477 000
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 70M 356M 363M 485M 335M
epsDiluted 1.48 7.53 7.68 10.23 7.09

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-28 2025-06-29 2024-12-31 2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2022-12-31 2022-09-25 2021-12-31 2020-12-31
symbol TFX TFX TFX TFX TFX TFX TFX TFX TFX TFX TFX TFX TFX TFX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943
fillingDate 2025-11-06 2025-07-31 2024-10-31 2024-08-02 2024-05-03 2023-11-03 2023-08-03 2023-05-04 2022-10-27
acceptedDate 2025-11-06 10:01:33 2025-07-31 11:05:11 2025-02-28 08:46:38 2024-10-31 11:38:17 2024-08-02 09:08:26 2024-05-03 12:41:46 2024-02-23 12:23:11 2023-11-03 08:09:18 2023-08-03 12:02:11 2023-05-04 12:32:42 2023-02-23 13:28:21 2022-10-27 12:16:31 2022-03-01 10:58:40 2021-02-25 12:34:16
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 354M 254M 290M 243M 239M 237M 223M 881M 251M 264M 292M 397M 445M 376M
shortTermInvestments 0 0 16M 0 16M 19M 0 68M 0 0 0 0 0 0
cashAndShortTermInvestments 354M 254M 306M 243M 239M 237M 223M 881M 251M 264M 292M 397M 445M 376M
netReceivables 593M 514M 459M 470M 449M 449M 443M 425M 429M 410M 409M 391M 384M 395M
inventory 802M 694M 600M 640M 637M 628M 626M 625M 632M 614M 579M 530M 478M 513M
otherCurrentAssets 237M 263M 102M 146M 133M 120M 107M 139M 120M 135M 125M 114M 117M 115M
totalCurrentAssets 1 986M 1 724M 1 471M 1 499M 1 438M 1 434M 1 407M 2 097M 1 446M 1 428M 1 411M 1 459M 1 429M 1 422M
propertyPlantEquipmentNet 808M 648M 612M 625M 604M 598M 603M 588M 588M 586M 578M 534M 573M 575M
goodwill 2 538M 2 694M 2 632M 2 919M 2 893M 2 898M 2 914M 2 528M 2 546M 2 548M 2 537M 2 415M 2 504M 2 586M
intangibleAssets 2 410M 2 184M 2 269M 2 325M 2 380M 2 429M 2 502M 2 181M 2 228M 2 270M 2 306M 2 176M 2 289M 2 520M
goodwillAndIntangibleAssets 4 948M 4 878M 4 901M 5 244M 5 273M 5 328M 5 416M 4 709M 4 774M 4 817M 4 843M 4 592M 4 793M 5 106M
longTermInvestments 14M 16M 0 0 1M -1 0 0 0 0 12M 0 0 0
taxAssets 14M 13M 11M 7M 6M 7M 7M 6M 6M 6M 6M 6M 7M 8M
otherNonCurrentAssets 103M 97M 103M 111M 119M 112M 99M 93M 82M 80M 77M 167M 69M 42M
totalNonCurrentAssets 5 886M 5 651M 5 627M 5 987M 6 004M 6 044M 6 125M 5 396M 5 450M 5 490M 5 517M 5 299M 5 443M 5 730M
otherAssets 0 0 0 0 0 1 0 0 0 0 0 0 0 0
totalAssets 7 872M 7 375M 7 098M 7 486M 7 442M 7 478M 7 533M 7 494M 6 896M 6 918M 6 928M 6 758M 6 872M 7 153M
accountPayables 166M 158M 141M 119M 113M 116M 132M 131M 142M 136M 127M 122M 118M 103M
shortTermDebt 100M 100M 100M 97M 94M 91M 88M 88M 88M 88M 88M 114M 110M 101M
taxPayables 0 22M 41M 19M 20M 49M 41M 24M 20M 30M 25M 41M 84M 17M
deferredRevenue 0 0 0 0 20M 49M 0 24M 20M 0 0 0 0 0
otherCurrentLiabilities 507M 436M 69M 384M 330M 316M 47M 343M 306M 352M 63M 375M 56M 54M
totalCurrentLiabilities 773M 716M 649M 619M 557M 571M 607M 585M 555M 576M 581M 611M 680M 540M
longTermDebt 2 669M 1 895M 1 556M 1 764M 1 727M 1 668M 1 728M 2 062M 1 583M 1 665M 1 624M 1 693M 1 740M 2 378M
deferredRevenueNonCurrent 0 0 0 0 103M 104M 0 30M 31M 0 0 0 0 0
deferredTaxLiabilitiesNonCurrent 424M 374M 391M 446M 453M 456M 456M 389M 385M 388M 389M 387M 370M 485M
otherNonCurrentLiabilities 184M 147M 124M 175M 146M 175M 190M 113M 126M 178M 191M 2 016M 211M 327M
totalNonCurrentLiabilities 3 277M 2 416M 2 170M 2 386M 2 326M 2 404M 2 485M 2 594M 2 125M 2 232M 2 325M 2 252M 2 437M 3 276M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 98M 94M 99M 103M 103M 104M 111M 112M 112M 116M 120M 100M 116M 86M
totalLiabilities 4 050M 3 132M 2 820M 3 005M 2 883M 2 975M 3 092M 3 180M 2 681M 2 808M 2 906M 2 863M 3 117M 3 816M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 48M 48M 48M 48M 48M 48M 48M 48M 48M 48M 48M 48M 48M 48M
retainedEarnings 3 879M 4 303M 4 116M 4 268M 4 173M 4 109M 4 110M 4 095M 3 973M 3 878M 3 817M 3 755M 3 518M 3 096M
accumulatedOtherComprehensiveIncomeLoss -264M -259M -317M -258M -279M -261M -314M -412M -382M -381M -404M -459M -347M -297M
othertotalStockholdersEquity 158M 150M 424M 617M 607M 584M 576M 566M 552M
totalStockholdersEquity 3 822M 4 243M 4 278M 4 482M 4 559M 4 503M 4 441M 4 314M 4 215M 4 110M 4 022M 3 895M 3 755M 3 336M
totalEquity 3 822M 4 243M 4 278M 4 482M 4 559M 4 503M 4 441M 4 314M 4 215M 4 110M 4 022M 3 895M 3 755M 3 336M
totalLiabilitiesAndStockholdersEquity 7 872M 7 375M 7 486M 7 442M 7 478M 7 494M 6 896M 6 918M 6 758M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 7 872M 7 375M 7 098M 7 486M 7 442M 7 478M 7 533M 7 494M 6 896M 6 918M 6 928M 6 758M 6 872M 7 153M
totalInvestments 14M 16M 16M 0 18M -1 0 68M 0 0 12M 0 0 0
totalDebt 2 769M 1 995M 1 755M 1 861M 1 821M 1 863M 1 926M 2 149M 1 670M 1 753M 1 832M 1 807M 1 966M 2 564M
netDebt 2 415M 1 741M 1 465M 1 618M 1 582M 1 625M 1 704M 1 268M 1 420M 1 489M 1 540M 1 410M 1 521M 2 189M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-28 2024-02-23 2023-02-23 2022-03-01 2021-02-25
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 459M 443M 409M 384M 395M
otherReceivables 0 0 0 0 0
prepaids 3M 7M 7M 6M 23M
totalPayables 182M 174M 152M 202M 120M
otherPayables 41M 41M 25M 84M 17M
accruedExpenses 298M 299M 279M 312M 266M
capitalLeaseObligationsCurrent 0 0 0 0 0
capitalLeaseObligationsNonCurrent 99M 111M 120M 116M 86M
treasuryStock -350M -152M -155M -157M -163M
additionalPaidInCapital 781M 750M 715M 693M 652M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-28 2025-06-29 2024-12-31 2024-09-29 2024-06-30 2024-03-31 2023-12-31 2023-10-01 2023-07-02 2023-04-02 2022-12-31 2022-09-25 2021-12-31 2020-12-31
symbol TFX TFX TFX TFX TFX TFX TFX TFX TFX TFX TFX TFX TFX TFX
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943 96 943
fillingDate 2025-11-06 2025-07-31 2024-10-31 2024-08-02 2024-05-03 2023-11-03 2023-08-03 2023-05-04 2022-10-27
acceptedDate 2025-11-06 10:01:33 2025-07-31 11:05:11 2025-02-28 08:46:38 2024-10-31 11:38:17 2024-08-02 09:08:26 2024-05-03 12:41:46 2024-02-23 12:23:11 2023-11-03 08:09:18 2023-08-03 12:02:11 2023-05-04 12:32:42 2023-02-23 13:28:21 2022-10-27 12:16:31 2022-03-01 10:58:40 2021-02-25 12:34:16
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome -409M 123M 70M 111M 80M 16M 356M 137M 111M 77M 363M 102M 485M 335M
depreciationAndAmortization 79M 66M 275M 69M 68M 66M 242M 58M 60M 60M 231M 56M 237M 227M
deferredIncomeTax 0 -2M 0 2M -5M -58M -13M 2M -2M 2M -13M -874 000 -110M -33M
stockBasedCompensation 8M 7M 31M 8M 9M 7M 31M 8M 7M 7M 27M 7M 23M 21M
changeInWorkingCapital -14M -141M -2M 48M -64M -58M -112M 17M -81M -60M -240M -8M 127M 22M
accountsReceivables -52M -37M -28M -14M -2M -10M -16M -2M -18M 1M -38M 8M -600 000 45M
inventory 56M -21M 2M 25M -12M -12M -41M -5M -16M -30M -111M -37M -11M -5M
accountsPayables 0 -3M 10M 33M 16M -51M -31M 37M -13M -41M -25M 12M 94M -4M
otherWorkingCapital -19M -80M 15M 4M -51M -36M -24M -13M -34M 10M -66M 9M 45M -13M
otherNonCashItems 443M -44M 262M -7M 162M 298M 6M -20M -10M -2M -26M -14M -111M -137M
netCashProvidedByOperatingActivities 108M 8M 636M 231M 91M 111M 511M 202M 86M 84M 342M 142M 651M 436M
investmentsInPropertyPlantAndEquipment -30M -35M -126M -21M -35M -38M -91M -24M -18M -22M -79M -20M -72M -91M
acquisitionsNet -826M -7M -120 000 -50 000 0 -70 000 -589M -76 000 -65 000 -64 000 -186M 8M 220M -766M
purchasesOfInvestments 0 0 -7M 0 -7M 0 -11M -11M 0 0 -22M 0 -18M 0
salesMaturitiesOfInvestments 0 8M 7M 0 7M 14M 7M 7M 0 0 7M 0 7M 0
otherInvestingActivites 89M 3M 0 5M 14M 454 000 10M 0 0
netCashUsedForInvestingActivites -768M -30M -21M -30M -25M -28M -7M -22M -13M
debtRepayment 774M -9M 40M -41M -57M -167M -79M -75M -9M
commonStockIssued 0 0 0 0 0 38 000 0 0 0
commonStockRepurchased -46 000 -2M -200M -200M 0 0 0 -38 000 0 0 -4M 0 0 0
dividendsPaid -15M -15M -16M -16M -16M -16M -16M -16M -16M
otherFinancingActivites -2M 2M 1M 598 000 2M 645M 3M -2M -905 000
netCashUsedProvidedByFinancingActivities 756M -24M -175M -57M -71M 462M -92M -94M -26M
effectOfForexChangesOnCash 916 000 13M -10M 4M -3M -151 000 3M -4M 306 000 4M -20M -15M -23M 21M
netChangeInCash 97M -34M 105M 39M 1M 15M -69M 631M -13M -28M -153M 89M 69M 75M
cashAtEndOfPeriod 381M 284M 328M 278M 239M 237M 223M 881M 251M 264M 292M 397M 445M 376M
cashAtBeginningOfPeriod 284M 317M 223M 239M 237M 223M 292M 251M 264M 292M 445M 308M 376M 301M
operatingCashFlow 108M 8M 636M 231M 91M 111M 511M 202M 86M 84M 342M 142M 651M 436M
capitalExpenditure -30M -35M -126M -21M -35M -38M -91M -24M -18M -22M -79M -20M -72M -91M
freeCashFlow 78M -27M 509M 210M 57M 73M 419M 177M 69M 62M 263M 122M 580M 346M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-28 2024-02-23 2023-02-23 2022-03-01 2021-02-25
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 27M 63M 22M 19M 19M
netCashProvidedByInvestingActivities -99M -621M -258M 157M -838M
netDebtIssuance -162M 101M -145M -635M 575M
longTermNetDebtIssuance -162M 101M -140M -635M 575M
shortTermNetDebtIssuance 0 0 -5M 0 0
netStockIssuance -200M 0 0 11M 0
netCommonStockIssuance -200M 0 0 11M 0
commonStockIssuance 0 0 4M 11M 0
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid -64M -64M -64M -64M -63M
commonDividendsPaid -64M -64M -64M -64M -63M
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities 3M 1M -8M -29M -57M
netCashProvidedByFinancingActivities -422M 39M -218M -716M 455M
incomeTaxesPaid 165M 114M 162M 109M 0
interestPaid 98M 100M 71M 74M 0

Earning call transcript

2025 q3
2025-11-06 ET (fiscal 2025 q3)
2025 q2
2025-07-31 ET (fiscal 2025 q2)
2025 q1
2025-05-01 ET (fiscal 2025 q1)
2024 q4
2025-02-27 ET (fiscal 2024 q4)
2024 q3
2024-10-31 ET (fiscal 2024 q3)
2024 q2
2024-08-01 ET (fiscal 2024 q2)
2024 q1
2024-05-02 ET (fiscal 2024 q1)
2023 q4
2024-02-22 ET (fiscal 2023 q4)
2023 q3
2023-11-05 ET (fiscal 2023 q3)
2023 q2
2023-08-03 ET (fiscal 2023 q2)
2023 q1
2023-05-06 ET (fiscal 2023 q1)
2022 q4
2023-02-23 ET (fiscal 2022 q4)
2022 q3
2022-10-27 ET (fiscal 2022 q3)
2022 q2
2022-07-28 ET (fiscal 2022 q2)
2022 q1
2022-04-28 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2026-05-07 10:30 ET
Teleflex Reports First Quarter Financial Results and Full Year 2026 Outlook
2026-04-30 10:30 ET
Teleflex Appoints Jason Weidman as President and CEO
2026-04-23 10:30 ET
Teleflex Announces First Quarter 2026 Earnings Conference Call Information
2026-03-27 ET
Irenic Comments on Teleflex’s Announcement That It Is Open to Strategic Alternatives
2026-03-27 ET
Teleflex Reiterates Commitment to Value Maximizing Strategies and Strong Execution
2026-03-27 ET
Irenic Sends Letter to Teleflex Board of Directors Regarding Its Refusal to Engage with Potential Acquirors
2026-03-12 ET
o9 Announces Teleflex™ Global Go-Live for Integrated Demand and Supply Planning
2026-02-26 ET
Teleflex Announces Quarterly Dividend
2026-02-26 ET
Teleflex Reports 2025 Financial Results and Full Year 2026 Outlook
2026-02-17 11:30 ET
Teleflex Announces Fourth Quarter 2025 Earnings Conference Call Information
2026-01-08 ET
Teleflex Announces Leadership Transition
2025-12-09 ET
Montagu and Kohlberg to Acquire Teleflex Medical OEM in a Carve-out Transaction
2025-12-09 ET
Teleflex Announces Sale of Acute Care, Interventional Urology, and OEM Businesses for $2.03 Billion
2025-11-14 ET
Teleflex to Present at the Jefferies Global Healthcare Conference in London
2025-11-06 ET
Teleflex Announces Quarterly Dividend
2025-11-06 ET
Teleflex Reports Third Quarter Financial Results and Full Year 2025 Outlook
2025-10-16 ET
Teleflex Announces Third Quarter 2025 Earnings Conference Call Information and Vascular Intervention Investor Virtual Meeting Details
2025-09-11 ET
First Patient Enrolled in DUBSTENT DIABETES Trial: Targeting Improved PCI Outcomes for Diabetic Patients
2025-08-26 ET
Teleflex to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
2025-08-19 ET
Teleflex Announces the Launch of Barrigel™ Rectal Spacer in Japan as a Proven Safe and Effective Option to Minimize the Harmful Long-Term Side Effects of Prostate Radiation Therapy
2025-07-31 ET
Teleflex Announces Quarterly Dividend
2025-07-31 ET
Teleflex Reports Second Quarter Financial Results and Full Year 2025 Outlook
2025-07-17 ET
Teleflex Announces Second Quarter 2025 Earnings Conference Call Information
2025-07-01 ET
Teleflex Completes Acquisition of BIOTRONIK’s Vascular Intervention Business
2025-06-12 ET
New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients
2025-06-11 ET
Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men’s Health Month
2025-05-19 ET
Teleflex Publishes 2024 Global Impact Report
2025-05-15 ET
Teleflex Showcases New Clinical Data Presented at the 2025 American Urological Association (AUA) Annual Meeting
2025-05-13 ET
New Retrospective Study Reports Significantly Reduced Post-Operative GERD Rates with the Titan SGS™ Stapler from Teleflex Compared with Multi-Fire Staplers in Sleeve Gastrectomy
2025-05-12 ET
Teleflex Announces Quarterly Dividend
2025-05-01 ET
Teleflex Reports First Quarter Financial Results and Full Year 2025 Outlook
2025-04-30 ET
Teleflex to Present at the BofA Securities 2025 Health Care Conference
2025-04-30 ET
Teleflex receives FDA 510(k) Clearance for Expanded Indications of the QuikClot Control+™ Hemostatic Device
2025-04-24 ET
Teleflex Announces Clinical and Real-World Evidence Studies and Physician Educational Opportunities to Be Highlighted at the 2025 American Urological Association (AUA) Annual Meeting
2025-04-17 ET
Teleflex Announces First Quarter 2025 Earnings Conference Call Information
2025-04-01 ET
Teleflex Receives FDA 510(k) Clearance of the AC3 Range™ Intra-Aortic Balloon Pump (IABP)
2025-03-27 ET
Preliminary Results from IDE Study on Ringer™ Perfusion Balloon Catheter (PBC) Reported from Podium at CTO Plus Conference
2025-03-25 ET
Teleflex Announces Updated Clinical Study Data Presented at the European Association of Urology (EAU) Congress
2025-02-27 ET
Teleflex Announces Quarterly Dividend
2025-02-27 ET
Teleflex Reports Fourth Quarter and Full Year 2024 Financial Results
2025-02-27 ET
Teleflex Announces Planned Retirement of Thomas Powell As Chief Financial Officer
2025-02-27 ET
Teleflex Announces Intent to Separate into Two Publicly Traded Companies
2025-02-27 ET
Teleflex to Acquire BIOTRONIK’s Vascular Intervention Business
2025-02-18 ET
Teleflex to Present at the Raymond James & Associates 46th Annual Institutional Investors Conference
2025-02-13 ET
Teleflex Announces Fourth Quarter 2024 Earnings Conference Call Information
2025-02-04 ET
Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer
2025-01-09 ET
Teleflex awarded Short Term Central Venous Catheters contract from Vizient
2025-01-07 ET
Teleflex to Present at the 43rd Annual J.P. Morgan Healthcare Conference
2024-11-19 ET
Teleflex to Present at the 36th Annual Piper Sandler Healthcare Conference
2024-11-07 ET
Teleflex to Present at the Jefferies London Healthcare Conference
2024-10-29 10:30 ET
First Patient Enrolled in Teleflex’s Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT)
2024-10-23 10:30 ET
Teleflex launches next-generation Arrow™ VPS Rhythm™ DLX Device and NaviCurve™ Stylet in Canada
2024-10-17 10:45 ET
New Data Presented at ASTRO 2024 Further Demonstrate the Safety and Efficacy of Barrigel™ Rectal Spacer, the First and Only Sculptable Hyaluronic Acid Rectal Spacer, in Patients Undergoing Radiation Therapy for Prostate Cancer(1-3)
2024-10-17 10:30 ET
Teleflex Announces Third Quarter 2024 Earnings Conference Call Information
2024-09-26 10:30 ET
Teleflex’s Barrigel Rectal Spacer to Be Featured in Three Presentations at the 2024 American Society for Radiation Oncology (ASTRO) Annual Meeting
2024-09-25 12:00 ET
Teleflex™ Chooses o9’s AI-Powered Platform for End-to-End Integrated Business Planning and Supply Chain Management
2024-08-22 10:30 ET
Teleflex to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
2024-08-01 10:45 ET
Teleflex Announces Quarterly Dividend
2024-08-01 10:30 ET
Teleflex Reports Second Quarter Financial Results and Full Year 2024 Outlook
2024-07-31 10:30 ET
Teleflex Expands Interventional Cardiology Portfolio with FDA 510(k) Clearance of the Ringer™ Perfusion Balloon Catheter
2024-07-29 10:30 ET
Teleflex Awarded Hemostasis Products Agreements with Premier, Inc.
2024-07-24 10:30 ET
Teleflex Announces the Teleflex Center for Antimicrobial Protection
2024-07-18 10:30 ET
Teleflex Announces Second Quarter 2024 Earnings Conference Call Information
2024-05-13 10:30 ET
Teleflex Publishes 2023 Global Impact Report
2024-05-09 10:30 ET
Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow™ EZ-IO™ Intraosseous Access Procedure Tray
2024-05-07 10:30 ET
Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH
2024-05-06 10:30 ET
Teleflex Announces Quarterly Dividend
2024-05-02 10:30 ET
Teleflex Reports First Quarter Financial Results and Full Year 2024 Outlook
2024-05-01 10:30 ET
Teleflex Announces Multiple Clinical and Real-World Evidence Studies to Be Highlighted at the 2024 American Urological Association Annual Meeting
2024-04-30 10:45 ET
Teleflex Announces the Limited Market Release of the Wattson™ Temporary Pacing Guidewire
2024-04-30 10:30 ET
Teleflex to Present at the BofA Securities 2024 Health Care Conference
2024-04-18 10:30 ET
Teleflex Announces First Quarter 2024 Earnings Conference Call Information
2024-04-02 10:30 ET
Teleflex Incorporated Introduces the UroLift™ 2 System With Advanced Tissue Control, a Revolutionary Unified Platform Designed to Treat All Prostate Types
2024-03-28 10:30 ET
Teleflex’s Climate Targets Validated by the Science Based Targets Initiative
2024-02-22 11:45 ET
Teleflex Announces Quarterly Dividend
2024-02-22 11:30 ET
Teleflex Reports Fourth Quarter and Full Year 2023 Financial Results
2024-02-20 11:30 ET
Teleflex to Present at the 45th Annual Raymond James Institutional Investors Conference
2024-02-08 11:30 ET
Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information
2024-01-09 11:30 ET
Teleflex now offers its Titan SGS™ Stapler with Staple Line Reinforcement
2023-12-26 11:30 ET
Teleflex to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-12-05 11:30 ET
Teleflex Awarded Peripheral Access Agreement with Premier, Inc.
2023-11-16 11:30 ET
Teleflex Announces First Patient Enrollment in ACCESS-MANTA™ Registry
2023-11-14 11:45 ET
Large-Scale Real-World Study Demystifies UroLift™ System Durability and Reinforces Superior Patient Experience for Men With Enlarged Prostate Compared to Leading Surgical Treatments
2023-11-14 11:30 ET
Teleflex to Present at the 35th Annual Piper Sandler Healthcare Conference
2023-11-02 10:45 ET
Teleflex Announces Quarterly Dividend
2023-11-02 10:30 ET
Teleflex Reports Third Quarter Financial Results and Full Year 2023 Outlook
2023-10-31 10:30 ET
Teleflex to Present at the Jefferies London Healthcare Conference
2023-10-19 10:30 ET
Teleflex Announces Third Quarter 2023 Earnings Conference Call Information
2023-10-10 21:00 ET
Teleflex Completes Acquisition of Palette Life Sciences
2023-09-15 10:30 ET
Teleflex Selected to Exhibit Arrow™ VPS Rhythm™ DLX Device and Arrow™ PICCs preloaded with the NaviCurve™ Stylet at Vizient Innovative Technology Exchange
2023-09-12 10:30 ET
New Survey Highlights the Quality of Life Impact of an Enlarged Prostate
2023-08-30 10:30 ET
Teleflex to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
2023-08-21 10:30 ET
Teleflex Announces Extension of Arrow™ ErgoPack™ Complete System to Hemodialysis and Large Bore Central Venous Catheters
2023-08-03 10:45 ET
Teleflex Announces Quarterly Dividend
2023-08-03 10:30 ET
Teleflex Reports Second Quarter Financial Results and Full Year 2023 Outlook
2023-08-01 10:30 ET
Teleflex Receives FDA Clearance for Expanded Indication for QuikClot Control+™ Hemostatic Device Usage in Cardiac Surgical Procedures
2023-07-26 10:44 ET
Palette Life Sciences Enters Into Definitive Agreement with Teleflex Incorporated
2023-07-26 10:30 ET
Teleflex to Acquire Palette Life Sciences
2023-07-25 10:30 ET
Teleflex Awarded National Group Purchasing Agreements with Premier, Inc.
2023-07-20 10:30 ET
Teleflex Announces Second Quarter 2023 Earnings Conference Call Information
2023-07-19 10:30 ET
Teleflex Completes Enrollment in Percutaneous Coronary Intervention Study
2023-06-21 21:00 ET
Teleflex Incorporated Announces Global Recall of Rüsch Endotracheal Tubes
2023-06-21 10:30 ET
Teleflex Announces Partnership with Insighters Medical for Exclusive Distribution of the Insighters® Video Laryngoscope System
2023-06-07 10:30 ET
Teleflex Receives FDA Clearance for the Wattson® Temporary Pacing Guidewire
2023-06-06 10:30 ET
Teleflex Announces the Arrow® EZ-IO® Needle Is Now FDA Cleared For Use in an MRI Environment
2023-06-01 10:30 ET
Teleflex Awarded Agreements with Premier, Inc.
2023-05-15 10:30 ET
Teleflex Publishes 2022 Global Impact Report
2023-05-08 10:30 ET
Teleflex Announces Quarterly Dividend
2023-05-04 10:30 ET
Teleflex Reports First Quarter Financial Results and Full Year 2023 Outlook
2023-05-03 10:30 ET
New Data Highlight that Early Intervention with the UroLift® System Facilitates Long-Term Outcomes for BPH Patients
2023-05-02 10:30 ET
Teleflex Launches New Arrow® VPS Rhythm® DLX Device and NaviCurve™ Stylet in the United States
2023-04-25 10:30 ET
Teleflex to Present at the Bank of America Securities 2023 Health Care Conference
2023-04-20 10:30 ET
Teleflex Announces First Quarter 2023 Earnings Conference Call Information
2023-03-29 10:30 ET
Teleflex Selects GORE® SEAMGUARD® Bioabsorbable Staple Line Reinforcement Material for Use with Innovative Titan SGS® Stapler
2023-03-13 10:30 ET
UroLift® System Research Data from EAU Highlight Durability and Superior Patient Experience, Along with Benefits of Earlier Treatment for BPH
2023-03-07 11:30 ET
Teleflex to Present at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum: Virtual
2023-02-23 11:45 ET
Teleflex Announces Quarterly Dividend
2023-02-23 11:30 ET
Teleflex Reports Fourth Quarter and Full Year 2022 Financial Results
2023-02-22 11:30 ET
Teleflex Expands Interventional Cardiology Portfolio with Two New FDA-Cleared Catheter Devices for Use in Complex Percutaneous Coronary Interventions (PCI)
2023-02-21 11:30 ET
Teleflex to Present at the 44th Annual Raymond James Institutional Investors Conference
2023-02-09 11:30 ET
Teleflex Announces Fourth Quarter 2022 Earnings Conference Call Information
2023-02-07 11:30 ET
Standard Bariatrics, Inc., now part of Teleflex, Awarded Bariatric Stapling Technology Agreement with Premier Inc.
2023-02-06 11:30 ET
Teleflex Launches National Ad Campaign — “Pit Stop” — to Raise Awareness of the UroLift® System as a Treatment for Enlarged Prostate
2022-12-27 11:30 ET
Teleflex to Present at the 41st Annual J.P. Morgan Healthcare Conference
2022-12-15 11:30 ET
Teleflex Celebrates 400,000 Patients Treated With the Minimally Invasive UroLift® System
2022-11-21 11:30 ET
Teleflex Earns Top Spot in MedReps Best Places to Work 2023 Ranking
2022-11-16 11:30 ET
Teleflex to Present at the 34th Annual Piper Sandler Healthcare Conference
2022-11-03 10:30 ET
Teleflex Announces Worldwide Recall of Gibeck® Iso-Gard® Filter
2022-11-01 10:30 ET
Teleflex to Present at the Jefferies London Healthcare Conference
2022-10-27 10:45 ET
Teleflex Announces Quarterly Dividend
2022-10-27 10:30 ET
Teleflex Reports Third Quarter Financial Results And Full Year Outlook
2022-10-25 10:30 ET
Published Data Demonstrate Consistent PUL Outcomes for the Treatment of Median Lobe Obstruction Across Controlled and Real-World Settings
2022-10-13 10:30 ET
Teleflex Announces Third Quarter 2022 Earnings Conference Call Information
2022-09-28 10:30 ET
Teleflex Completes Acquisition of Standard Bariatrics
2022-09-27 10:30 ET
Teleflex launches new Arrow® Pressure Injectable Midline Catheter Portfolio
2022-09-15 10:30 ET
Co-Author of the Karolinska 1000 Consecutive MANTA® Vascular Closure Device Study to Present Learnings at the Transcatheter Cardiovascular Therapeutics (TCT) 2022 Conference
2022-08-31 10:30 ET
Teleflex to Present at the Morgan Stanley 20th Annual Global Healthcare Conference
2022-08-25 10:30 ET
Teleflex Announces Collaboration with FundamentalVR, to Improve Training Through Virtual Reality Simulation
2022-08-22 10:30 ET
Teleflex to Expand Its Surgical Portfolio with Differentiated Stapling Technology for Bariatric Surgery
2022-08-01 10:30 ET
Teleflex awarded Central Venous Access contract from Vizient
2022-07-29 10:30 ET
Teleflex Publishes 2021 Global Impact Report
2022-07-28 10:45 ET
Teleflex Announces Quarterly Dividend
2022-07-28 10:30 ET
Teleflex Reports Second Quarter Financial Results And Full Year Outlook
2022-07-21 10:30 ET
Teleflex Announces Pocono Raceway NASCAR Event to Raise Visibility of Enlarged Prostate and the Importance of Regular Health Screenings
2022-07-14 10:30 ET
Teleflex Announces Second Quarter 2022 Earnings Conference Call Information
2022-07-01 10:30 ET
New Data Reinforce Efficacy of the UroLift® System for the Treatment of Enlarged Prostate
2022-06-22 10:30 ET
Teleflex Announces First Patient Enrollment in MANTA Ultra Study
2022-06-07 04:30 ET
Teleflex launches new Arrow Pressure Injectable Midline Catheter in Europe, the Middle East and Africa region
2022-06-01 10:30 ET
Teleflex Celebrates June Men’s Health Month with Launch of UroLift® Patient Ambassador Program
2022-05-20 10:30 ET
Teleflex Hosts 2022 Analyst & Investor Day
2022-05-19 10:30 ET
Teleflex Announces Regulatory Clearance for its UroLift® System in China for the Treatment of Benign Prostatic Hyperplasia (BPH)
2022-05-18 10:30 ET
Teleflex Announces Health Canada Approval of MANTA® Vascular Closure Device
2022-05-13 10:30 ET
Teleflex Announces Full U.S. Commercial Launch of the UroLift® 2 System and UroLift ATC ® Advanced Tissue Control System
2022-05-02 10:45 ET
Teleflex to Host Analyst & Investor Day on May 20, 2022
2022-05-02 10:30 ET
Teleflex Announces Quarterly Dividend
2022-04-28 10:30 ET
Teleflex Reports First Quarter Financial Results And Full Year Outlook
2022-04-26 10:45 ET
Teleflex Named to Forbes Best Employers for Diversity 2022 List
2022-04-26 10:30 ET
Teleflex to Present at the Bank of America Securities 2022 Healthcare Conference
2022-04-14 10:30 ET
Teleflex Announces First Quarter 2022 Earnings Conference Call Information
2022-04-11 10:30 ET
Teleflex Announces the Launch of the UroLift® System in Japan for the Treatment of Benign Prostatic Hyperplasia (BPH)
2022-03-09 11:30 ET
Teleflex to Present at the KeyBanc Life Sciences & MedTech Investor Forum
2022-03-02 11:30 ET
Teleflex to Present at the 43rd Annual Raymond James Institutional Investors Conference
2022-02-24 11:45 ET
Teleflex Announces Quarterly Dividend
2022-02-24 11:30 ET
Teleflex Announces Fourth Quarter and Full-Year 2021 Financial Results
2022-02-23 11:30 ET
Teleflex Receives FDA Clearance for Expanded Indication for Specialty Catheter and Coronary Guidewire Use in CTO PCI Procedures
2022-02-10 11:30 ET
Teleflex Announces Fourth Quarter and Full Year 2021 Earnings Conference Call Information
2022-01-04 11:30 ET
Teleflex to Present at the 40th Annual J.P. Morgan Healthcare Conference
2021-12-13 11:30 ET
Teleflex Receives Reimbursement Approval for the UroLift® System in Japan
2021-11-26 23:00 ET
Teleflex Incorporated Announces Worldwide Recall of Arrow-Trerotola™ Over-The-Wire PTD® Kit Percutaneous Thrombolytic Device: 7FR
2021-11-18 11:45 ET
Teleflex Earns Top Spot in MedReps Best Places to Work 2022 Ranking
2021-11-18 11:30 ET
Teleflex to Participate in the 33rd Annual Virtual Piper Sandler Healthcare Conference
2021-11-04 10:30 ET
Teleflex Integrates Medical Education and Training with Explorer Surgical to Expand Urologists’ Access to Procedural Expertise
2021-11-03 10:47 ET
Teleflex Comments on the Centers for Medicare & Medicaid Services 2022 Medicare Physician Fee Schedule Final Rule
2021-10-29 10:30 ET
The UroLift® System Receives Bronze Award for Best New Branded Television Campaign and Honorable Mention in the Best Branded Website Category from DTC Perspectives
2021-10-28 10:45 ET
Teleflex Announces Quarterly Dividend
2021-10-28 10:30 ET
Teleflex Reports Third Quarter 2021 Results and Full Year Outlook
2021-10-27 10:30 ET
Teleflex Completes Enrollment in Cardiac IDE Study
2021-10-14 10:30 ET
Teleflex Announces Third Quarter 2021 Earnings Conference Call Information
2021-09-14 10:30 ET
Teleflex Announces Large-Scale Analysis of Real-World Healthcare Claims Data for Enlarged Prostate Procedures at the American Urological Association 2021 Annual Meeting
2021-09-09 10:30 ET
Teleflex Unveils the UroLift Advanced Tissue Control (ATC)® System and the UroLift® 2 System and Real-World Data Presentations at the American Urological Association 2021 Annual Meeting
2021-09-01 10:30 ET
Teleflex to Present at the Morgan Stanley 19th Annual Global Healthcare Conference
2021-08-30 10:30 ET
New Study Provides Insights into the Biocompatibility and Durability of the UroLift® System in Improving Benign Prostatic Hyperplasia Symptoms
2021-08-26 10:30 ET
Teleflex to Present at the Wells Fargo 2021 Virtual Healthcare Conference
2021-07-29 10:45 ET
Teleflex Announces Quarterly Dividend
2021-07-29 10:30 ET
Teleflex Reports Second Quarter 2021 Results and Full Year Outlook
2021-07-15 10:30 ET
Teleflex Announces Second Quarter 2021 Earnings Conference Call Information
2021-07-09 10:30 ET
Largest U.S. Healthcare Claims and Utilization Analysis for BPH Procedures Reveals Lowest Overall Complication Rates and Consistent Durability after Treatment with Minimally Invasive UroLift System
2021-07-06 10:30 ET
Teleflex Announces Real-World Clinical Data Presentations of the UroLift® System at the 36th Annual European Association of Urology Congress
2021-06-28 21:00 ET
Teleflex Completes Divestiture of Respiratory Assets to Medline Industries
2021-06-16 10:30 ET
New Data Suggest Men with Urinary Symptoms Often Anticipate Bathroom Needs and Avoid Events and Activities They Enjoy
2021-06-07 10:30 ET
Teleflex to Present at the Raymond James 2021 Human Health Innovation Conference
2021-05-18 10:30 ET
Teleflex Signs Definitive Agreement to Sell Certain Respiratory Assets and Reaffirms Adjusted EPS Guidance
2021-05-11 10:30 ET
Teleflex to Present at the UBS Global Healthcare Virtual Conference
2021-05-03 10:30 ET
Teleflex Announces Quarterly Dividend
2021-04-29 10:30 ET
Teleflex Reports First Quarter 2021 Results
2021-04-27 10:30 ET
Teleflex to Present at the Bank of America Securities 2021 Virtual Health Care Conference
2021-04-15 10:30 ET
Teleflex Announces First Quarter 2021 Earnings Conference Call Information
2021-03-11 07:00 ET
UroLift® System, a proven treatment for Benign Prostatic Hyperplasia (BPH), now reimbursed in France
2021-03-10 11:30 ET
Teleflex to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum
2021-03-09 11:30 ET
Teleflex Reports 250,000 Patients Treated for Enlarged Prostate With the Minimally Invasive UroLift® System
2021-02-25 11:45 ET
Teleflex Announces Quarterly Dividend
2021-02-25 11:30 ET
Teleflex Reports Fourth Quarter and Full Year 2020 Results; Provides 2021 Guidance
2021-02-24 11:30 ET
Teleflex Announces Submission of Biologics License Application for Its Investigational Freeze Dried Plasma
2021-02-23 11:30 ET
Teleflex to Present at Barclays Global Healthcare Conference
2021-02-17 11:30 ET
Teleflex Completes Enrollment in CTO-PCI IDE Study
2021-02-16 11:30 ET
Teleflex Named One of America’s Best Employers 2021 by Forbes
2021-02-16 11:30 ET
Teleflex to Present at the Raymond James 42nd Annual Institutional Investors Conference
2021-02-11 11:30 ET
Teleflex Announces Fourth Quarter and Full Year 2020 Earnings Conference Call Information
2021-01-20 11:30 ET
Published Data Demonstrate Sexual Function Improvement and Preservation with the Minimally Invasive UroLift® System Compared to Medications Prescribed for Benign Prostatic Hyperplasia
2021-01-19 11:30 ET
Teleflex continues to deliver COMPLETE confidence with new Arrow® ErgoPack® Complete MAC, PSI Systems
2021-01-04 11:30 ET
Teleflex to Present at the 39th Annual J.P. Morgan Healthcare Conference
2020-12-28 22:22 ET
DW Healthcare Partners and Linden Announce Sale of Z-Medica to Teleflex
2020-12-28 22:00 ET
Teleflex Completes Acquisition of Market Leader in Hemostatic Products
2020-12-03 11:30 ET
Teleflex Ranked a Best Place to Work 2021 by MedReps.com
2020-11-19 11:30 ET
Research Reinforcing the Effectiveness and Safety of the UroLift® System in the Real-World Setting Presented at 50th Annual ICS Meeting
2020-11-02 11:30 ET
Teleflex to Present at the Stephens Investment Conference 2020
2020-10-29 10:45 ET
Teleflex Announces Quarterly Dividend
2020-10-29 10:30 ET
Teleflex Reports Third Quarter 2020 Results
2020-10-28 21:00 ET
Teleflex to Acquire Market Leader in Hemostatic Products
2020-10-28 10:30 ET
Teleflex Interventional Urology Expands Portfolio with Introduction of the UroLift® Advanced Tissue Control (ATC)™ System
2020-10-27 10:30 ET
Teleflex Delivers COMPLETE Confidence with the New Arrow® ErgoPack® Complete CVC System
2020-10-19 10:30 ET
Teleflex Announces Third Quarter 2020 Earnings Conference Call Information
2020-10-08 10:30 ET
Teleflex Named One of America’s Best-In-State Employers 2020 by Forbes
2020-10-01 10:30 ET
Teleflex Announces Expanded Indications for the Arrow® EZ-IO® Intraosseous Vascular Access System
2020-09-02 10:30 ET
Teleflex to Present at the Morgan Stanley 18th Annual Global Healthcare Conference
2020-08-26 10:30 ET
Teleflex to Present at the Wells Fargo 2020 Virtual Healthcare Conference
2020-08-18 10:30 ET
Teleflex Publishes 2nd Annual Global JOIN Impact Report
2020-07-30 10:45 ET
Teleflex Announces Quarterly Dividend
2020-07-30 10:30 ET
Teleflex Reports Second Quarter 2020 Results
2020-07-30 10:00 ET
Teleflex Announces 200,000 Patients Treated with UroLift System for Enlarged Prostate
2020-07-21 10:30 ET
Teleflex Announces Positive Data Emphasizing the Effectiveness of the UroLift® System Treatment for Enlarged Prostate Across Broad Patient Populations
2020-07-20 10:30 ET
Teleflex Announces Second Quarter 2020 Earnings Conference Call Information
2020-07-14 10:30 ET
New Data Suggest Men May Want Non-Drug Alternatives For Treatment of Enlarged Prostate Symptoms
2020-06-23 10:30 ET
Teleflex COVID 19 Humanitarian Product Donation Program
2020-06-22 10:30 ET
Teleflex Announces Publication of Early Patient Experience Data Highlighting the UroLift® System as a Superior Treatment to Rezum™ Steam Injection in Patients with Enlarged Prostate
2020-06-08 21:00 ET
In Honor of Men’s Health Month, Teleflex Announces Virtual Community Health Talk for Men with Benign Prostatic Hyperplasia
2020-06-03 10:45 ET
Teleflex to Present at the Raymond James 2020 Human Health Innovation Conference
2020-06-02 10:30 ET
Teleflex Announces First Patient Enrollment in CTO-PCI IDE Study
2020-05-21 21:00 ET
Teleflex Incorporated Announces Pricing of $500 Million Senior Notes Offering
2020-05-21 12:49 ET
Teleflex Incorporated Announces Private Offering of $500 Million of Senior Notes due 2028
2020-05-18 10:30 ET
Teleflex Announces Positive Data Showing that the UroLift® System Effectively Relieves Enlarged Prostate Symptoms While Preserving Patients’ Sexual Function*
2020-05-04 10:45 ET
Teleflex Announces Quarterly Dividend
2020-05-04 10:30 ET
Teleflex to Present at the UBS Virtual Global Healthcare Conference
2020-04-30 10:30 ET
Teleflex Reports First Quarter 2020 Results
2020-04-29 21:15 ET
Teleflex awarded Central Venous Access, Arterial Access agreements with Premier
2020-04-29 21:00 ET
ISO-Gard® Oxygen Mask Provides Oxygen Delivery While Scavenging Exhaled Breath
2020-04-29 10:45 ET
Teleflex to Present at the Bank of America Merrill Lynch 2020 Health Care Conference
2020-04-20 21:00 ET
TELEFLEX ANNOUNCES FIRST QUARTER 2020 EARNINGS CONFERENCE CALL INFORMATION
2020-04-17 10:45 ET
Teleflex Announces 2020 Annual Meeting of Stockholders to be Held in Virtual-Only Format
2020-03-11 10:45 ET
Teleflex Celebrates 175,000 Patients Treated with the UroLift® System
2020-02-25 11:45 ET
Teleflex to Present at Barclays Global Healthcare Conference
2020-02-20 11:45 ET
Teleflex Announces Quarterly Dividend
2020-02-20 11:30 ET
Teleflex Reports Fourth Quarter and Full Year 2019 Results; Provides 2020 Guidance
2020-02-18 22:00 ET
Teleflex to Present at the Raymond James 41st Annual Institutional Investors Conference
2020-02-14 22:00 ET
Teleflex Incorporated Announces Worldwide Voluntary Recall of COMFORT FLO® Humidification System
2020-02-13 22:00 ET
Teleflex to Present at the 9th Annual SVB Leerink Global Healthcare Conference
2020-02-06 11:45 ET
Teleflex Announces Fourth Quarter and Full Year 2019 Earnings Conference Call Information
2020-01-22 11:30 ET
Teleflex Receives FDA Clearance for Wattson™ Temporary Pacing Guidewire
2020-01-14 11:30 ET
Teleflex Convenes Urologists in Australia for Summit on Treating Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms
2020-01-07 11:30 ET
Teleflex Announces FDA Clearance for Expanded Indication of the UroLift® System for Treatment of Larger Prostates, Up to 100cc
2020-01-02 11:45 ET
Teleflex to Present at the 38th Annual J.P. Morgan Healthcare Conference
2019-12-30 11:45 ET
Teleflex to Present at the Goldman Sachs 12th Annual Healthcare CEOs Unscripted: A View from the Top
2019-12-19 11:45 ET
Teleflex Ranked a Best Place to Work by MedReps.com
2019-11-21 11:45 ET
Teleflex to Present at the 31st Annual Piper Jaffray Healthcare Conference
2019-11-11 11:45 ET
Teleflex to Showcase its Interventional Portfolio Highlighting the MANTA® Vascular Closure Device and the Langston® Dual Lumen Catheters at the PCR London Valves 2019
2019-04-18 10:45 ET
Teleflex Announces First Quarter 2019 Earnings Conference Call Information 
2019-03-26 10:30 ET
Teleflex Publishes Inaugural Corporate Social Responsibility (CSR) Report
2019-03-21 10:30 ET
Teleflex Announces Real-World Data Demonstrating the Effectiveness of the UroLift® System to Treat Patients with Enlarged Prostate  

SEC forms

Show financial reports only

SEC form 8
2026-06-01 22:35 ET
Teleflex published news for 2026 q1
SEC form 8
2026-06-01 22:35 ET
Teleflex published news for 2026 q1
SEC form 8
2026-06-01 11:59 ET
Teleflex published news for 2026 q1
SEC form 8
2026-06-01 11:59 ET
Teleflex published news for 2026 q1
SEC form 8
2026-06-01 11:59 ET
Teleflex published news for 2026 q1
SEC form 10
2026-05-07 17:33 ET
Teleflex published news for 2026 q1
SEC form 8
2026-05-07 11:04 ET
Teleflex published news for 2026 q1
SEC form 8
2026-05-07 11:04 ET
Teleflex published news for 2026 q1
SEC form 8
2026-05-07 11:04 ET
Teleflex published news for 2026 q1
SEC form 8
2026-03-27 18:48 ET
Teleflex published news for 2025 q4
SEC form 8
2026-03-27 18:48 ET
Teleflex published news for 2025 q4
SEC form 10
2026-02-27 21:11 ET
Teleflex published news for 2025 q4
SEC form 8
2026-02-26 07:00 ET
Teleflex published news for 2025 q4
SEC form 8
2026-02-26 07:00 ET
Teleflex reported for 2025 q4
SEC form 8
2026-02-26 07:00 ET
Teleflex published news for 2025 q4
SEC form 8
2026-01-08 11:55 ET
Teleflex published news for 2025 q4
SEC form 8
2026-01-08 11:55 ET
Teleflex published news for 2025 q4
SEC form 10
2025-11-06 10:01 ET
Teleflex reported for 2025 q3
SEC form 8
2025-11-06 07:00 ET
Teleflex published news for 2025 q3
SEC form 8
2025-11-06 07:00 ET
Teleflex published news for 2025 q3
SEC form 8
2025-11-06 07:00 ET
Teleflex published news for 2025 q3
SEC form 10
2025-07-31 15:05 ET
Teleflex reported for 2025 q2
SEC form 8
2025-07-31 11:00 ET
Teleflex published news for 2025 q2
SEC form 8
2025-07-31 11:00 ET
Teleflex published news for 2025 q2
SEC form 8
2025-07-31 11:00 ET
Teleflex published news for 2025 q2
SEC form 10
2025-05-01 15:49 ET
Teleflex reported for 2025 q1
SEC form 8
2025-05-01 11:00 ET
Teleflex published news for 2025 q1
SEC form 8
2025-05-01 11:00 ET
Teleflex published news for 2025 q1
SEC form 8
2025-05-01 11:00 ET
Teleflex published news for 2025 q1
SEC form 10
2025-05-01 00:00 ET
Teleflex published news for 2025 q1
SEC form 10
2025-02-28 08:46 ET
Teleflex reported for 2024 q4
SEC form 10
2025-02-28 00:00 ET
Teleflex published news for 2024 q4
SEC form 10
2024-10-31 11:38 ET
Teleflex reported for 2024 q3
SEC form 8
2024-10-31 07:00 ET
Teleflex published news for 2024 q3
SEC form 8
2024-10-31 07:00 ET
Teleflex published news for 2024 q3
SEC form 8
2024-10-31 07:00 ET
Teleflex published news for 2024 q3
SEC form 10
2024-10-31 00:00 ET
Teleflex published news for 2024 q3
SEC form 10
2024-08-02 09:08 ET
Teleflex published news for 2024 q2
SEC form 10
2024-08-02 00:00 ET
Teleflex published news for 2024 q2
SEC form 8
2024-08-01 07:00 ET
Teleflex published news for 2024 q2
SEC form 8
2024-08-01 07:00 ET
Teleflex reported for 2024 q2
SEC form 8
2024-08-01 07:00 ET
Teleflex published news for 2024 q2
SEC form 10
2024-05-03 12:41 ET
Teleflex published news for 2024 q1
SEC form 10
2024-05-03 00:00 ET
Teleflex published news for 2024 q1
SEC form 8
2024-05-02 07:00 ET
Teleflex published news for 2024 q1
SEC form 8
2024-05-02 07:00 ET
Teleflex reported for 2024 q1
SEC form 8
2024-05-02 07:00 ET
Teleflex published news for 2024 q1
SEC form 10
2024-02-23 12:23 ET
Teleflex published news for 2023 q4
SEC form 10
2024-02-23 00:00 ET
Teleflex published news for 2023 q4
SEC form 8
2024-02-22 07:00 ET
Teleflex published news for 2023 q4
SEC form 8
2024-02-22 07:00 ET
Teleflex reported for 2023 q4
SEC form 8
2024-02-22 07:00 ET
Teleflex published news for 2023 q4
SEC form 10
2023-11-03 08:09 ET
Teleflex published news for 2023 q3
SEC form 10
2023-11-03 00:00 ET
Teleflex published news for 2023 q3
SEC form 8
2023-11-02 07:00 ET
Teleflex reported for 2023 q3
SEC form 10
2023-08-03 12:02 ET
Teleflex published news for 2023 q2
SEC form 6
2023-08-03 07:00 ET
Teleflex reported for 2023 q2
SEC form 10
2023-08-03 00:00 ET
Teleflex published news for 2023 q2
SEC form 8
2023-08-03 00:00 ET
Teleflex published news for 2023 q2
SEC form 6
2023-06-26 15:23 ET
Teleflex published news for 2023 q1
SEC form 10
2023-05-04 00:00 ET
Teleflex published news for 2023 q1
SEC form 8
2023-05-04 00:00 ET
Teleflex published news for 2023 q1
SEC form 6
2023-03-24 16:40 ET
Teleflex published news for 2022 q4
SEC form 10
2023-02-23 13:28 ET
Teleflex reported for 2022 q4
SEC form 6
2023-02-23 07:00 ET
Teleflex published news for 2022 q4
SEC form 10
2023-02-23 00:00 ET
Teleflex reported for 2022 q4
SEC form 8
2023-02-23 00:00 ET
Teleflex reported for 2022 q4
SEC form 6
2022-11-21 16:02 ET
Teleflex published news for 2022 q3
SEC form 6
2022-11-10 16:08 ET
Teleflex published news for 2022 q3
SEC form 10
2022-10-27 12:16 ET
Teleflex reported for 2022 q3
SEC form 6
2022-10-27 07:00 ET
Teleflex published news for 2022 q3
SEC form 10
2022-10-27 00:00 ET
Teleflex reported for 2022 q3
SEC form 8
2022-10-27 00:00 ET
Teleflex reported for 2022 q3
SEC form 10
2022-07-28 11:03 ET
Teleflex reported for 2022 q2
SEC form 6
2022-07-28 07:00 ET
Teleflex published news for 2022 q2
SEC form 10
2022-07-28 00:00 ET
Teleflex reported for 2022 q2
SEC form 8
2022-07-28 00:00 ET
Teleflex reported for 2022 q2
SEC form 6
2022-06-24 15:47 ET
Teleflex published news for 2022 q1
SEC form 6
2022-06-03 07:56 ET
Teleflex published news for 2022 q1
SEC form 6
2022-05-20 07:28 ET
Teleflex published news for 2022 q1
SEC form 6
2022-05-09 17:22 ET
Teleflex published news for 2022 q1
SEC form 6
2022-05-05 17:18 ET
Teleflex published news for 2022 q1
SEC form 10
2022-04-28 10:25 ET
Teleflex reported for 2022 q1
SEC form 6
2022-04-28 07:01 ET
Teleflex published news for 2022 q1
SEC form 10
2022-04-28 00:00 ET
Teleflex reported for 2022 q1
SEC form 8
2022-04-28 00:00 ET
Teleflex reported for 2022 q1
SEC form 6
2022-03-30 16:31 ET
Teleflex published news for 2021 q4
SEC form 6
2022-03-09 17:05 ET
Teleflex published news for 2021 q4
SEC form 10
2022-03-01 10:58 ET
Teleflex published news for 2021 q4
SEC form 10
2022-03-01 00:00 ET
Teleflex published news for 2021 q4
SEC form 6
2022-02-25 17:06 ET
Teleflex published news for 2021 q4
SEC form 6
2022-02-24 07:00 ET
Teleflex published news for 2021 q4
SEC form 8
2022-02-24 00:00 ET
Teleflex published news for 2021 q4
SEC form 10
2021-10-28 10:17 ET
Teleflex published news for 2021 q3
SEC form 6
2021-10-28 07:02 ET
Teleflex published news for 2021 q3
SEC form 10
2021-10-28 00:00 ET
Teleflex published news for 2021 q3
SEC form 8
2021-10-28 00:00 ET
Teleflex published news for 2021 q3
SEC form 10
2021-07-29 10:27 ET
Teleflex published news for 2021 q2
SEC form 6
2021-07-29 07:15 ET
Teleflex published news for 2021 q2
SEC form 10
2021-07-29 00:00 ET
Teleflex published news for 2021 q2
SEC form 8
2021-07-29 00:00 ET
Teleflex published news for 2021 q2
SEC form 6
2021-06-29 15:52 ET
Teleflex published news for 2021 q1
SEC form 6
2021-06-07 16:38 ET
Teleflex published news for 2021 q1
SEC form 6
2021-05-28 17:11 ET
Teleflex published news for 2021 q1
SEC form 6
2021-05-18 06:47 ET
Teleflex published news for 2021 q1
SEC form 6
2021-05-05 20:57 ET
Teleflex published news for 2021 q1
SEC form 10
2021-04-29 11:03 ET
Teleflex published news for 2021 q1
SEC form 6
2021-04-29 07:00 ET
Teleflex published news for 2021 q1
SEC form 10
2021-04-29 00:00 ET
Teleflex published news for 2021 q1
SEC form 8
2021-04-29 00:00 ET
Teleflex published news for 2021 q1
SEC form 6
2021-03-26 16:39 ET
Teleflex published news for 2020 q4
SEC form 10
2021-02-25 12:34 ET
Teleflex published news for 2020 q4
SEC form 6
2021-02-25 07:00 ET
Teleflex published news for 2020 q4
SEC form 10
2020-10-29 09:59 ET
Teleflex published news for 2020 q3
SEC form 6
2020-10-29 07:02 ET
Teleflex published news for 2020 q3